Back

Login or Register
to download FREE PDF book

Existing user LOGIN
OR
New user REGISTRATION

Register Fill in details Download
User registration PDF download (#5)

Register Fill in details Download

Your download has started.

If the download didn't start automatically, then please click here.

Thank you for the interest in
Practical Approaches to Risk Minimisation for Medicinal Products: Report of CIOMS Working Group IX

We welcome your feedback on this publication.

Explore more publications

PUBLICATIONS

Practical Approaches to Risk Minimisation for Medicinal Products: Report of CIOMS Working Group IX

The Council for International Organizations of Medical Sciences (CIOMS) announces the publication of Practical approaches to risk minimisation for medicinal products: Report of CIOMS Working Group IX. Medical science continues to bridge new frontiers with an ever-widening array of medicinal products to treat illnesses and health conditions.  No medicine is devoid of risk, however, and for that reason, it becomes paramount to appropriately manage all kinds of risks, from the very minor ones t Read more...
  • In Stock
  • isbn: 978 92 9036 084 4
  • Year of publication: 2014
  • Number of pages: 184
  • SKU: 97

Hardcopy paperback at reduced price to increase access. Postage will be added.

1 00 CHF

Amount:


"Practical Approaches to Risk Minimisation for Medicinal Products: Report of CIOMS Working Group IX" reviews

There are no reviews yet.

×

Please leave your review for Practical Approaches to Risk Minimisation for Medicinal Products: Report of CIOMS Working Group IX

Be the first to review “Practical Approaches to Risk Minimisation for Medicinal Products: Report of CIOMS Working Group IX”

Your email address will not be published. Required fields are marked *

The maximum upload file size: 300 MB. You can upload: image. Links to YouTube, Facebook, Twitter and other services inserted in the comment text will be automatically embedded. Drop file here

The Council for International Organizations of Medical Sciences (CIOMS) announces the publication of Practical approaches to risk minimisation for medicinal products: Report of CIOMS Working Group IX.

Medical science continues to bridge new frontiers with an ever-widening array of medicinal products to treat illnesses and health conditions.  No medicine is devoid of risk, however, and for that reason, it becomes paramount to appropriately manage all kinds of risks, from the very minor ones to those with serious adverse effects, with the objective being a positive balance of benefits to risks.  Risk management of medicines is a wide and rapidly evolving concept and practice, following a medicine throughout its lifecycle, from first administration in humans through clinical studies and then marketing in the patient population at large.

Previous reports from CIOMS I – VIII provided practical guidance in some essential components of risk management such as terminology and  reporting of adverse drug reactions, management of safety information from clinical trials, and safety signal detection.  Beyond the detection, identification, and characterisation of risk, “risk minimisation” is used as an umbrella term for the prevention or mitigation of an undesirable outcome.

Risk management always includes tools for “routine risk minimisation” such as product information, the format depending on the jurisdiction, to inform the patient and the prescriber, all of which serve to prevent or mitigate adverse effects.   Until this current CIOMS IX document, limited guidance has been available on how to determine which risks need “additional risk minimisation,” select the appropriate tools, apply and implement such tools globally and locally, and measure if they are effective and valuable.  Included in the report is a CIOMS framework for the evaluation of effectiveness of risk minimisation, a discussion of future trends and developments, an annex specifically addressing vaccines, and examples from real life.

Citation of document:  Practical approaches to risk minimisation for medicinal products: Report of CIOMS Working Group IX.  Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS), 2014.